千金药业：公司获得药品注册证书

Core Points - Qianjin Pharmaceutical announced the approval of two new drug registration certificates by the National Medical Products Administration for its subsidiary Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. [2] Group 1 - The approved drugs include Fumaric Acid Vonoprazan Tablets (20mg, 10mg) and Empagliflozin Tablets (10mg, 25mg) [2]